By B. Rune. Indiana University.
The same group conducted an 8-week super levitra 80mg discount erectile dysfunction doctors in chandigarh, open- label study of olanzapine in patients with borderline personality disorder and comorbid dys- thymia (82) generic super levitra 80mg visa erectile dysfunction pills over the counter. Among the 11 completers, significant improvement was reported across all domains, with particular improvement noted in depression, interpersonal sensitivity, psychoticism, anxiety, and anger/ hostility. In summary, neuroleptics are the best-studied psychotropic medications for borderline personality disorder. The literature supports the use of low-dose neuroleptics for the acute management of global symptom severity, with specific efficacy for schizotypal symptoms and psychoticism, anger, and hostility. Relief of global symptom severity in the acute setting may be due, in part, to nonspecific “tranquilizer” effects of neuroleptics, whereas symptom-specific actions against psychoticism, anger, and hostility may relate more directly to dopaminergic blockade. Acute treatment effects of neuroleptic drugs in borderline personality disorder tend to be modest but clinically and statistically significant. Two studies that addressed continuation and maintenance treatment of a patient with border- line personality disorder with neuroleptics had contradictory results. The Montgomery and Mont- gomery study (80) reported efficacy for recurrent parasuicidal behaviors, whereas the Cornelius et al. More controlled trials are needed to investigate low-dose neuroleptics in continuation and maintenance treatment. In acute studies, patient nonadherence is often due to typical medication side effects, e. Patients with borderline personality disorder who have experienced relief of acute symptoms with low-dose neuroleptics may not tolerate the side effects of the drug with longer-term treatment. The risk of tardive dyskinesia must be considered in any decision to continue neuroleptic medication over the long term. Thioridazine has been associated with cardiac rhythm disturbances related to widening of the Q-T interval and should be avoided. In the case of clozapine, the risk of agranulocytosis is es- pecially problematic. While the newer atypical neuroleptics promise a more favorable side effect profile, evidence of efficacy in borderline personality disorder is still awaited. Neuroleptics should be given in the context of a supportive doctor-patient relationship in which side effects and nonadherence are addressed frequently. Treatment of Patients With Borderline Personality Disorder 65 Copyright 2010, American Psychiatric Association. With the exception of one study that used a depot neuroleptic (flupentixol, which is not available in the United States), all medications were given orally and daily. Acute treatment studies are a good model for acute clinical care and typically range from 5 to 12 weeks in duration. There is insuf- ficient evidence to make a strong recommendation concerning continuation and maintenance therapies. At present, this is best left to the clinician’s judgment after carefully weighing the risks and benefits for the individual patient. Although studies that used a naturalistic design have had inconsistent findings, patients with major depression and a comorbid personality disorder were generally less responsive to somatic treatments than patients with major depression alone. In one naturalistic follow-up study (based on chart review), there was no significant dif- ference in recovery rates for 10 patients with major depressive disorder and a personality dis- order (40% recovery) compared with 41 patients with major depressive disorder alone (65. In another study, involving 1,471 depressed inpatients, depressed patients with a personality disorder were 50% less likely to be recovered at hospital discharge than de- pressed patients without a personality disorder (193). Several uncontrolled studies found that outcome was dependent on the time of assessment. Conversely, in another uncontrolled study of inpatients with major depression (195), compared with depressed patients without a personality disorder, those with a personality disorder had a poorer outcome in terms of depression and social functioning immediately follow- ing treatment. However, after 6 and 12 weeks of follow-up, there were no differences between the two groups in terms of depression and social functioning. The number of rehospitalizations did not differ between groups at the 6-month and 12-month follow-up evaluations. Improvements were noted in passive-aggressive and borderline personality traits that did not reach statistical significance. These symptoms should ideally be confirmed by out- side observers, as they provide an objective way to assess treatment response. Knowledge of the patient’s personality functioning before the onset of major depression is critical to knowing when the “baseline” has been achieved. Notable progress has been made in our understanding of borderline personality disorder and its treatment. However, there are many remaining questions regarding treatments with demonstrated efficacy, including how to optimally use them to achieve the best health outcomes for patients with borderline personality disorder. In addition, many therapeutic modalities have received little empirical investigation for borderline personality disorder and require further study. The efficacy of various treatments also needs to be studied in populations such as adolescents, the elderly, forensic populations, and patients in long-term institutional settings. The following is a sample of the types of research questions that require further study. For example, further controlled treatment studies of psychodynamic psychothera- py, dialectical behavior therapy, and other forms of cognitive behavior therapy are needed, partic- ularly in outpatient settings.
Such action may include reevaluating work practices super levitra 80 mg online erectile dysfunction due to old age, re-training personnel buy discount super levitra 80 mg erectile dysfunction drugs free sample, performing thor- ough deactivation, decontamination, cleaning, and improving engineering controls. Repeat the wipe sampling to validate that the deactivation/decontamination and cleaning steps have been effective. Disposable gowns made of polyethylene-coated polypropylene or other laminate materials offer better protection than those made of uncoated materials. If no permeation information is available for the gowns used, change them every 2–3 hours or immediately after a spill or splash. Disposable sleeve covers made of polyethylene-coated polypropylene or other laminate materials offer better protection than those made of un- coated materials. Eye glasses alone or safety glasses with side shields do not protect the eyes adequately from splashes. Face shields in combination with goggles provide a full range of protection against splashes to the face and eyes. A surgical N95 respirator provides the respiratory protection of an N95 respirator, and like a surgical mask, provides a barrier to splashes, droplets, and sprays around the nose and mouth. The entity must enforce policies that include a tiered approach, starting with visual examination of the shipping container for signs of damage or breakage (e. Table 4 summarizes the steps for receiving and handling of damaged shipping containers. Compounding must be done in proper engineering controls as described in Compounding. The mat should be changed immediately if a spill occurs and regularly during use, and should be discarded at the end of the daily compounding activity. Liquid formu- lations are preferred if solid oral dosage forms are not appropriate for the patient. Additionally, sterile compounding areas and devices must be subsequently disinfected. The entity must establish written procedures for decontamination, deactivation, and cleaning, and for sterile compounding areas disinfection. Additionally, cleaning of nonsterile compounding areas must comply with á795ñ and cleaning of sterile com- pounding areas must comply with á797ñ. Written procedures for cleaning must include procedures, agents used, dilutions (if used), frequency, and documentation requirements. Additionally, eye protection and face shields must be used if splashing is likely. Consult manu- facturer or supplier information for compatibility with cleaning agents used. Care should be taken when selecting materials for deactivation due to potential ad- verse effects (hazardous byproducts, respiratory effects, and caustic damage to surfaces). Damage to surfaces is exhibited by corrosion to stainless steel surfaces caused by sodium hypochlorite if left untreated. To prevent corrosion, sodium hypochlorite must be neutralized with sodium thiosulfate or by following with an agent to remove the sodium hypochlorite (e. To provide protection to the worker performing this task, respiratory protection may be required. Cleaning agents used on compound- ing equipment should not introduce microbial contamination. Disinfection must be done for areas intended to be sterile, including the sterile compounding areas. Written procedures should address use of appro- priate full-facepiece, chemical cartridge-type respirators if the capacity of the spill kit is exceeded or if there is known or sus- pected airborne exposure to vapors or gases. Medical surveillance programs involve assessment and documentation of symptom complaints, physical find- ings, and laboratory values (such as a blood count) to determine whether there is a deviation from the expected norms. Medical surveillance can also be viewed as a secondary prevention tool that may provide a means of early detection if a health problem develops. Tracking personnel through medical surveillance allows the comparison of health variables over time in individual workers, which may facilitate early detection of a change in a laboratory value or health condition. In this manner, medical surveillance acts as a check on the effectiveness of controls already in use. The entity should take the following actions: • Perform a post-exposure examination tailored to the type of exposure (e. An assessment of the extent of exposure should be conducted and included in a confidential database and in an incident report. The physical examination should focus on the involved area as well as other organ systems commonly affected (i. Treatment and laboratory studies will follow as indicated and be guided by emergency protocols • Compare performance of controls with recommended standards; conduct environmental sampling when analytical meth- ods are available • Verify and document that all engineering controls are in proper operating condition • Verify and document that the worker complied with existing policies. The ante-room is the transition room between the unclassified area of the facility and the buffer room. Assessment of risk: Evaluation of risk to determine alternative containment strategies and/or work practices.
Table 1: Standards and regulations relevant to this guidance Subject Medicines management in residential services for older people and people with disabilities Audience Providers of services for older people and people with disabilities in designated centres Standards and regulations relevant to this guide include Standards Number Regulation Number 4 buy cheap super levitra 80 mg on line impotence due to diabetes, 6 quality 80 mg super levitra men's health erectile dysfunction pills, 7, National Standards for Health Act 2007 (Care and Welfare of 16, 21, Residential Care Settings 3. This guidance explains concepts that aim to help service providers meet regulations and implement national standards. It intends to enable service providers to identify the regulations, standards and good practice relevant to their service. Please note other 7 Medicines Management Guidance Health Information and Quality Authority requirements relevant to a particular service may not be addressed here. All nurses should be familiar with An Bord Altranais agus Cnáimhseachais na hÉireann’s most up to date ‘Guidance to Nurses and Midwives on Medicines Management’ and the online learning tools provided. It provides the right support at the right time to enable residents to lead their lives in as fulfilling and safe a way as possible. A key principle of service delivery is that residents in receipt of services are central in all aspects of planning, delivery and reviews of their care. Person-centred services involve a collaborative multidisciplinary partnership between all those engaged in the delivery of care and support. Residents and their relatives, with the resident’s permission, are central to this partnership. Residents are actively involved in determining the services they receive and are empowered to exercise their human and individual rights. This includes the right to be treated equally in the allocation of services and supports, and the right to refuse a service or some element of a service. Residents take medicines for their therapeutic benefits, and to support and improve their health conditions. Medicines management covers a number of tasks including assessing, supplying, prescribing, dispensing, administering, reviewing and assisting people with their medicines. Policies and procedures outlining the parameters of the assistance that can be provided should be in place to support this. Residents may choose to self administer medicines with or without help and support from staff, where the risks of doing so have been comprehensively assessed. Any changes to this risk assessment must be recorded and arrangements for self administration of medicines kept under review. Medicines are only administered with the resident’s consent and the resident has the right to refuse medicines. Residents should be provided with information on medicines and be included in decisions about their own medicines and treatment. Policies and procedures outline the process for obtaining consent and the measures to be undertaken if a resident refuses medicines. A structured set of policies and procedures should be in place to govern effective medicines management in the residential service. Management and staff of residential services should work together to ensure that medicines management policies and procedures are comprehensive, appropriate, robust and up-to-date. It is good practice to audit all aspects of medicines management practice to ensure that policies and procedures are safe, appropriate, consistent and effectively monitored. Policies and procedures should be continuously evaluated and reviewed objectively by the service to ensure that medicines management is continuously improved. Service providers must also audit and review adherence by staff to the medicines management policies and procedures in the service and take appropriate action when these documented policies and procedures are not being adhered to. Policies for risk management, management of behaviour that is challenging (positive behaviour management), the use of restraint, training and staff development, infection control (for example), and all other relevant policies should also be considered. All policies and procedures for medicines management must be reviewed, at a minimum, every three years or sooner if required. This makes sure that it is clear who is accountable and responsible for managing medicines safely and effectively in residential services. It is important that residential services’ staff have the appropriate safeguards in place to ensure correct checking of the medicines ordered and received. Good practice in the ordering of medicines outlines that residential service providers should ensure sufficient numbers of staff in the residential service have the training and skills to order medicines. Care should be taken to make sure that only current required prescribed medicines are ordered, to prevent an overstock. Medicines delivered to or collected by the residential service should be checked against a record of the order to make sure that all medicines ordered have been prescribed and supplied correctly: The dispensed supply is checked against the ordered medicines. Prescriptions must take into account the needs and views of the resident, or representatives where appropriate, policies of the residential service, legislative requirements, local and national clinical guidelines, and professional standards. In some situations, registered dental practitioners or registered nurse prescribers may prescribe medicines. All prescriptions should be legible and contain all the information as required by the regulations.
10 of 10 - Review by B. Rune
Votes: 286 votes
Total customer reviews: 286